Skip to main content
BIO KEY INTERNATIONAL INC logo

BIO KEY INTERNATIONAL INC — Investor Relations & Filings

Ticker · BKYI ISIN · US09060C3097 LEI · 549300VFT6WAQB4BVB07 US Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 1,005 across all filing types
Latest filing 2026-05-18 Earnings Release
Country US United States of America
Listing US BKYI

About BIO KEY INTERNATIONAL INC

https://www.bio-key.com/

BIO KEY INTERNATIONAL INC is a provider of Identity and Access Management (IAM) and biometric identity solutions. The company develops technologies aimed at creating a secure, passwordless, and phishing-resistant environment for users. Its core offering is the PortalGuard platform, an IAM and Identity-as-a-Service (IDaaS) solution that provides multi-factor authentication (MFA), single sign-on (SSO), and self-service password reset capabilities. A key differentiator is its proprietary Identity-Bound Biometrics, particularly fingerprint identification technology, which is designed for rapid and accurate user verification. BIO-key offers flexible deployment options, including SaaS, hybrid, and on-premises, to support various organizational security strategies such as cloud migration and securing remote workforces.

Recent filings

Filing Released Lang Actions
FORM 8-K
Earnings Release Classification · 90% confidence The document is a Form 8-K “Current Report” filed under Item 2.02 (“Results of Operations and Financial Condition”) reporting the issuance and furnishing of a press release announcing first quarter 2026 financial results. It does not contain the full interim financial statements but rather attaches a press release with earnings highlights. This matches the definition of an Earnings Release (ER). Q1 2026
2026-05-18 English
8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC by BIO-key International, Inc. It primarily announces that the company received a notice from Nasdaq regarding non-compliance with a listing rule due to failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2025. The document includes a press release about this matter but does not contain the actual Annual Report or financial statements. The length is under 5,000 characters and the content is an announcement of a regulatory issue and related press release, not the report itself. Therefore, this fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance notice rather than the Annual Report or Delisting Announcement categories.
2026-04-22 English
8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
Earnings Release Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated April 16, 2026. It announces the issuance of a press release containing the company's results of operations for the first quarter ended March 31, 2026. The text explicitly states that the information is included in a press release attached as Exhibit 99.1 and that this Form 8-K is a current report, not the full financial report itself. The document length is 3455 characters, which is relatively short and consistent with an announcement rather than a full report. The content corresponds to an initial announcement of quarterly financial results, which fits the definition of an Earnings Release (ER).
2026-04-20 English
8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
Report Publication Announcement Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated March 31, 2026. It announces the issuance of a press release containing the company's financial results for the fourth quarter and full year ending December 31, 2025. The text explicitly states that the press release is attached as an exhibit and that the information is not deemed filed for certain regulatory purposes. The document itself does not contain detailed financial statements or substantive financial data but rather announces the release of such information. The length of the document is 3456 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, according to the MENU VS MEAL RULE and the nature of the content, this document should be classified as a Report Publication Announcement (RPA).
2026-03-31 English
8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated March 3, 2026. It announces the issuance of a press release containing financial results for the year-end 2025 cash position. The document itself does not contain detailed financial statements or substantive financial data but rather references an attached press release (Exhibit 99.1). The text explicitly states that the information is not deemed "filed" for certain regulatory purposes and is primarily an announcement of the press release. The document length is 3573 characters, which is relatively short and consistent with an announcement rather than a full financial report. According to the "Menu vs Meal" rule, this is an announcement of a report rather than the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement and does not fit into more specific categories like Earnings Release or Annual Report.
2026-03-04 English
4 Filing
Director's Dealing
2026-01-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.